Applied Biopharm Consulting partners with South East Technological University to advance viral vector research

CORK, REPUBLIC OF IRELAND. May 20th, 2026 – Applied Biopharm Consulting Ltd has announced a new research collaboration with the Pharmaceutical and Molecular Biotechnology Research Centre (PMBRC) at the South East Technological University (SETU) in Waterford, Ireland, to experimentally validate aspects of its artificial intelligence (AI)-driven biomolecular research programme. The collaboration is supported through the […]

Applied Biopharm Consulting partners with South East Technological University to advance viral vector research Read More »

Treaty-Filed DNA Licensing Rail Launches: GENOMIRATHEON™ with 461 Licenses

WILMINGTON, DE, UNITED STATES, September 10th, 2025 – Neon Parody Labs today announced the launch of GENOMIRATHEON™, a new DNA licensing platform that transforms gene activity into legally recognised, trackable records. By linking biology directly with licensing rights, payments, and compliance systems, the platform introduces a new way to create legal and financial records through

Treaty-Filed DNA Licensing Rail Launches: GENOMIRATHEON™ with 461 Licenses Read More »

HairLabs Unveils Anti Grey 1.0 – First AI-Enhanced Hair Nutraceutical Built to Safeguard Stem Cells

Twenty years of stem-cell research and advanced AI compound analyses distilled into two vegan capsules powered by the proprietary NooPigment Matrix™. LONDON, UK. June 17th 2025 – HairLabs, the London biotech start-up focused on hair healthspan, today announces Anti Grey 1.0, a daily supplement engineered to help preserve the melanocyte stem-cell (MSC) reservoir that powers

HairLabs Unveils Anti Grey 1.0 – First AI-Enhanced Hair Nutraceutical Built to Safeguard Stem Cells Read More »

Modern Synthesis secures $5.5M to commercialise groundbreaking biomaterial technology

Leading climate investors are backing Modern Synthesis’ biomaterial technology to reduce emissions and plastic pollution from fashion, footwear, and automotive industries. LONDON, UK. February 5th, 2025 – Modern Synthesis, a biotechnology company pioneering the development of microbially-derived biomaterials, today announces the successful close of a $5.5 million funding round. The oversubscribed round was led by

Modern Synthesis secures $5.5M to commercialise groundbreaking biomaterial technology Read More »

Applied Biopharm Consulting Secures Grant to Evaluate Capsid Engineering Technology for Improved Gene Therapy Delivery

Laura Johnson

CORK, IRELAND, March 05, 2024 – Applied Biopharm Consulting Ltd has been awarded a grant from the Local Enterprise Office Cork North and West to fund a feasibility study, as part of an office-based assessment, to engineer viral capsids and other molecules using artificial intelligence and advanced computational tools. The grant will also be used

Applied Biopharm Consulting Secures Grant to Evaluate Capsid Engineering Technology for Improved Gene Therapy Delivery Read More »

Perpetua Life Announces Launch of Perpetua Life Biotech UK Ltd

Laura Johnson

Pioneering US Startup focused on longevity supplementation establishes Local UK presence LONDON, UK. 12th January 2024 – In a significant stride towards global expansion, Perpetua Life Biotech, a U.S.-based startup specialising in gerontology and longevity medicine, proudly announces the establishment of Perpetua Life Biotech UK Ltd. The newly formed UK entity aims to enhance accessibility

Perpetua Life Announces Launch of Perpetua Life Biotech UK Ltd Read More »

biotechnology